NL-OMON51960RecruitingNot Applicable
ext generation sequencing in patients with pancreatic ductal adenocarcinoma (PAN-NGS). A nationwide prospective, translational cohort study. - PAN-NGS
Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites300 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 300
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Cytological or histologically confirmed PDAC, irrespective of treatment
- •Age > 18 years and <= 60 years at date of primary diagnosis;
- •Performance status of ECOG 0-2;
- •Estimated life expectancy of at least 12 weeks;
- •Written informed consent.
Exclusion Criteria
- •Unwilling to know if there are any alterations which might be associated with
- •genetic predisposition of cancer;
- •Patient with locally-advanced PDAC or local-recurrence of PDAC with no
- •histological tissue available for NGS.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
ext generation sequencing in patients with pancreatic ductal adenocarcinoma (PAN-NGS). A nationwide prospective, translational cohort studyPancreatic cancerNL-OMON21085Erasmus MC300
Unknown
Not Applicable
Genomic biomarker research for advanced pancreatic cancer and neuroendocrine tumor.JPRN-UMIN000022960Chiba Cancer Center230
Completed
Not Applicable
Study for genetic susceptibility to pancreatic cancerpancreatic cancerJPRN-UMIN000016984Center for Clinical and Biomedical Research, Sapporo Higashi Tokushukai Hospital100
Terminated
Phase 1
Investigation of gemcitabine combined with temsirolimus, in patients with inoperable or metastatic pancreatic cancer. A phase I-II study by the Hellenic Cooperative Oncology Group with biomarker evaluation (HE3/07)Patients with inoperable or metastatic pancreatic cancerCancer - PancreaticACTRN12611000643976Hellenic Cooperative Oncology Group85
Not yet recruiting
Not Applicable
Follow up of patients of Indeterminate for chronic pancreatitis for 1 yearCTRI/2019/08/020632Arun Vaidya